Patents by Inventor Amy J. Hall

Amy J. Hall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8815306
    Abstract: Methods and compositions that can be used to promote bone and joint health through amelioration, stabilization and repair of damage associated with various pathophysiological conditions are disclosed.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: August 26, 2014
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Anu Desai, Amy J. Hall, Jeffrey S. Bland
  • Patent number: 8475850
    Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: July 2, 2013
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Amy J. Hall, Anu Desai, Jeffrey S. Bland
  • Publication number: 20130064913
    Abstract: Disclosed are botanically based compositions and methods useful for the treatment of metabolic syndrome and diabetes type 2. Compositions, kits, and methods are additionally disclosed for means to augment the activity of identified glucose and insulin regulating drugs.
    Type: Application
    Filed: June 1, 2012
    Publication date: March 14, 2013
    Applicant: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Amy J. Hall, Veera Konda, Linda M. Pacioretty
  • Patent number: 8263139
    Abstract: Botanical compounds to modulate kinase activity are disclosed. The compounds and methods disclosed also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively. The compositions contain at least one fraction isolated or derived from hops or Acacia.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: September 11, 2012
    Assignee: Metaproteonics, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Linda M. Pacioretty, Jeffrey S. Bland, Amy J. Hall, Veera Konda, Anu Desai
  • Patent number: 8206753
    Abstract: Disclosed are botanically based compositions and methods useful for the treatment of metabolic syndrome and diabetes type 2. Compositions, kits, and methods are additionally disclosed for means to augment the activity of identified glucose and insulin regulating drugs.
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: June 26, 2012
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Amy J. Hall, Veera Konda, Linda M. Pacioretty
  • Patent number: 7901714
    Abstract: Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed.
    Type: Grant
    Filed: January 4, 2007
    Date of Patent: March 8, 2011
    Assignee: Metaproteomics, LLP
    Inventors: Matthew L. Tripp, Jeffrey S. Bland, Robert Lerman, Amy J. Hall, Veera Konda, Anu Desai
  • Publication number: 20100069422
    Abstract: Methods and compositions that can be used to promote bone and joint health through amelioration, stabilization and repair of damage associated with various pathophysiological conditions are disclosed.
    Type: Application
    Filed: November 25, 2009
    Publication date: March 18, 2010
    Applicant: METAPROTEOMICS, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Anu Desai, Amy J. Hall, Jeffrey S. Bland
  • Publication number: 20080248131
    Abstract: Botanical compounds to modulate kinase activity are disclosed. The compounds and methods disclosed also inhibit expression of COX-2, inhibit synthesis o prostaglandins selectively in target cells, and inhibit inflammatory response selectively. The compositions contain at least one fraction isolated or derived from hops or Acacia.
    Type: Application
    Filed: August 9, 2006
    Publication date: October 9, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Amy J. Hall, Veera Konda, Anu Desai
  • Publication number: 20080242690
    Abstract: Methods and compositions that can be used to promote bone and joint health through amelioration, stabilization and repair of damage associated with various pathophysiological conditions are disclosed.
    Type: Application
    Filed: March 14, 2008
    Publication date: October 2, 2008
    Inventors: Matthew L. Tripp, Veera Konda, Anu Desai, Amy J. Hall, Jeffrey S. Bland